The cellular basis of dilated cardiomyopathy in humans

C. A. Beltrami, N. Finato, M. Rocco, G. A. Feruglio, C. Puricelli, E. Cigola, E. H. Sonnenblick, G. Olivetti, P. Anversa. The Cellular Basis of Dilated Cardiomyopathy in Humans. Journal of Molecular and Cellular Cardiology (1995) 27, 291–305. The present investigation was designed to evaluate whethe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular and cellular cardiology 1995, Vol.27 (1), p.291-305
Hauptverfasser: Beltrami, Carlo Alberto, Finato, Nicoletta, Rocco, Maurizio, Feruglio, Giorgio A., Puricelli, Cesare, Cigola, Elena, Sonnenblick, Edmund H., Olivetti, Giorgio, Anversa, Piero
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:C. A. Beltrami, N. Finato, M. Rocco, G. A. Feruglio, C. Puricelli, E. Cigola, E. H. Sonnenblick, G. Olivetti, P. Anversa. The Cellular Basis of Dilated Cardiomyopathy in Humans. Journal of Molecular and Cellular Cardiology (1995) 27, 291–305. The present investigation was designed to evaluate whether end-stage cardiac failure in patients affected by dilated cardiomyopathy (DC) was dependent upon extensive myocyte cell death with reduction in muscle mass or was the consequence of collagen accumulation in the myocardium independently from myocyte cell loss. In addition, the mechanisms of ventricular dilation were analysed in order to determine whether the changes in cardiac anatomy were important variables in the development of intractable congestive heart failure. DC is characterized by chamber dilation, myocardial scarring and myocyte hypertrophy in the absence of significant coronary atherosclerosis. However, the relative contribution of each of these factors to the remodeling of the ventricle is currently unknown. Moreover, no information is available concerning the potential etiology of collagen deposition in the myocardium and the changes in number and size of ventricular myocytes with this disease. Morphometric methodologies were applied to the analysis of 10 DC hearts obtained from patients undergoing cardiac transplantation. An identical number of control hearts was collected from individuals who died from cruises other than cardiovascular diseases. DC produced a 2.2-fold and 4.2-/bid increase in left ventricular weight and chamber vohnne resuking in a 48% reduction in mass-to-volume ratio. In the right ventricle, tissue weight and chamber size were both nearly doubled. Left ventricular dilation was the result of a 59% lengthening of myocytes and a 20% increase in the transverse circumference due to slippage of myocytes within the wall. Myocardial scarring represented by segmental, replacement and interstitial fibrosis occupied approximately 20% of each ventricle, and was indicative of extensive myocyte cell loss. However, myocyte number was not reduced and average cell volume increased 2-fold in both ventricles. In conclusion, reactive growth processes in myocytes and architectural rearrangement of the muscle compartment of the myocardium appear to be the major determinants of ventricular remodeling and the occurrence of cardiac failure in DC.
ISSN:0022-2828
1095-8584
DOI:10.1016/S0022-2828(08)80028-4